Toronto, Ontario – September 12, 2019– Nutritional High International Inc. (“Nutritional High” or the “Company“) (CSE: EAT, OTCQB: SPLIF) is pleased to announce a distribution relationship in California with PurBlend Science, Inc makers of the VOOZTM vapor delivery system, through its wholly owned subsidiary, Calyx Brands.
VOOZ is a next generation pod-based delivery system, combining a unique hardware design accommodating many types of oil including high viscosity, uncut cannabis oil, resulting in superior delivery of flavor and potency for the user.
“VOOZ is truly a new generation of all-in-one pod-based vaping systems,” said Mark Vuozzo, CEO of PurBlend Science. “The vPod snaps into place via a magnet, allows for easy swapping of flavors or oil type on the go. VOOZ excels in performance for very thick CBD/THC oils and resin.”
According to BDS Analytics* concentrates, usually sold as vapes, are the most popular product in California, the largest American recreational market. Last year in California, cannabis concentrates outsold flower (37 percent compared to 33 percent) for the first time in history.
The VOOZ pod-based vaping system features a unique 1.0ml/0.5ml V-Pod design utilizing gravity feed. A nano-tech ceramic coil with increased surface area and improved airflow helps deliver optimal draw and flavor. Pods feature a larger hole, making it easy for consumers to customize their experience by filling their own pods. A magnetic base allows for easy changing of pods.
“Consumers are wanting to move beyond the traditional 510-threaded vape cart,” said Dakota Sullivan, CEO of Calyx Brands. “The VOOZ pod system delivers a vaping experience that people find uniquely satisfying in both true cannabis flavor and high impact pulls.”
For more information, please visit Calyx Brands at Hall of Flowers, Booth B319, September 18 & 19, Sonoma County Fairgrounds, Santa Rosa, CA.
* BDS Analytics February, 2019, “The 2018 California Cannabis Marketplace in Review”
About Nutritional High International Inc.
Nutritional High is focused on developing, manufacturing and distributing products under recognized brands in the cannabis products industry, with a specific focus on edibles and oil extracts for medical and adult recreational use. The Company works exclusively with licensed facilities in jurisdictions where such activity is permitted and regulated by state law.
The Company follows a vertically integrated model with a fully developed strategy for acquisitions in extraction, production, sales, and distribution sectors of the cannabis industry. Nutritional High has brought its flagship FLÏ™ edibles and extracts product line from production to market through its wholly owned subsidiaries in California and Oregon, as well as Colorado where its FLÏ™ products are manufactured by a third-party licensed producer. In California, the Company distributes its products and products manufactured by other leading producers through its wholly owned distributor Calyx Brands Inc. and is entering the Nevada, Washington State and Canadian markets in the near future.
For updates on the Company’s activities and highlights of the Company’s press releases and other media coverage, please follow Nutritional High on Facebook, Twitter and Instagram or visit www.nutritionalhigh.com.
For further information, please contact:
Chairman of the Board
Nutritional High International Inc.
Director, Investor Relations
Nutritional High International Inc.
NEITHER THE CANADIAN SECURITIES EXCHANGE NOR OTC MARKETS GROUP INC., NOR THEIR REGULATIONS SERVICES PROVIDERS HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
This news release may contain forward-looking statements and information based on current expectations. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. The statements relate to potential market expansion and the use of the proceeds of the Offering. Risks that may have an impact on the ability for these events to be achieved include completion of due diligence, negotiation of definitive agreements and receipt of applicable approvals. Although such statements are based on management’s reasonable assumptions, there can be no assurance that such assumptions will prove to be correct. We assume no responsibility to update or revise them to reflect new events or circumstances.
The Company’s securities have not been registered under the U.S. Securities Act of 1933, as amended (the “U.S. Securities Act“), or applicable state securities laws, and may not be offered or sold to, or for the account or benefit of, persons in the United States or “U.S. Persons”, as such term is defined in Regulation S under the U.S. Securities Act, absent registration or an applicable exemption from such registration requirements. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in the United States or any jurisdiction in which such offer, solicitation or sale would be unlawful.
Additionally, there are known and unknown risk factors which could cause the Company’s actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained herein. All forward-looking information herein is qualified in its entirety by this cautionary statement, and the Company disclaims any obligation to revise or update any such forward-looking information or to publicly announce the result of any revisions to any of the forward-looking information contained herein to reflect future results, events or developments, except as required by law. Some of the risks and other factors that could cause actual results to differ materially from those expressed in forward-looking information expressed in this press release include, but are not limited to: obtaining and maintaining regulatory approvals including acquiring and renewing U.S. state, local or other licenses, the uncertainty of existing protection from U.S. federal or other prosecution, regulatory or political change such as changes in applicable laws and regulations, including U.S. state-law legalization, market and general economic conditions of the cannabis sector or otherwise.